Singulair and Tarpeyo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Singulair (montelukast sodium) and Tarpeyo (budesonide). Common drug interactions include hypertension among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Singulair and Tarpeyo. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.

What is Tarpeyo?

Tarpeyo has active ingredients of budesonide. eHealthMe is studying from 2,758 Tarpeyo users. Check the latest studies of Tarpeyo.

On Aug, 01, 2026

18 people who take Singulair and Tarpeyo together, and have interactions are studied.

Singulair and Tarpeyo drug interactions.

What are the common drug interactions of Singulair and Tarpeyo, by gender? *:

female:

Hypertension (high blood pressure)
Muscle spasms (muscle contraction)
Blood potassium decreased
Blood pressure increased
Energy increased
Fluid retention (an abnormal accumulation of fluid in the blood)
Malaise (a feeling of general discomfort or uneasiness)
Peripheral swelling
Therapeutic response unexpected
Asthenia (weakness)

male:

Abdominal discomfort
Dry mouth
Skin atrophy (wasting of skin)
Swelling
Thirst
Weight increased
Haemorrhagic diathesis (bleeding tendency)
Heart rate increased
Hunger
Hypersensitivity

What are the common drug interactions of Singulair and Tarpeyo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Hypersensitivity
Swelling
Weight increased

40-49:

Blood pressure increased
Haemorrhagic diathesis (bleeding tendency)
Peripheral swelling
Sinusitis (inflammation of sinus)
Skin atrophy (wasting of skin)

50-59:

Muscle spasms (muscle contraction)
Abdominal discomfort
Blood potassium decreased
Energy increased
Fluid retention (an abnormal accumulation of fluid in the blood)
Hypertension (high blood pressure)
Malaise (a feeling of general discomfort or uneasiness)
Therapeutic response unexpected
Blood creatinine increased
Blood glucose increased

60+:

Asthenia (weakness)
Contusion (a type of hematoma of tissue in which capillaries)
Weight increased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dry mouth
Face injury
Fall
Fatigue (feeling of tiredness)
Joint injury
Oral herpes (viral infection of mouth)

What are the existing conditions these people have? *

Iga Nephropathy (kidney disease- condition prevents the kidneys from filtering waste): 11 people, 61.11%
Haematuria (presence of blood in urine): 5 people, 27.78%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 2 people, 11.11%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Singulair and Tarpeyo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously